Cytomegalovirus Disease in Transplant Recipients

• FDA approval · 2022-10-04
  FDA Approved: VALGANCICLOVIR — Original Application (Camber Pharmaceuticals, Inc.)

  FDA approved Camber Pharmaceuticals' generic valganciclovir hydrochloride under an original ANDA (ANDA 211475), adding a generic option for …

• FDA approval · 2020-03-12
  FDA Approved: VALGANCICLOVIR HYDROCHLORIDE — Supplemental Application (NorthStar Rx LLC)

  The FDA approved a supplemental application for valganciclovir hydrochloride by NorthStar Rx LLC, enabling a generic valganciclovir product.